Watson, Alan M <br/><br/>
Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Dec 2012 
 - 5549-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.1102221  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Neoplasm--genetics<br/>Antigens, Polyomavirus Transforming--genetics<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cross-Priming--genetics<br/>Epitopes, T-Lymphocyte--genetics<br/>Lymphocyte Activation--genetics<br/>Lymphocyte Count<br/>Major Histocompatibility Complex--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Peptides--metabolism<br/>Protein Stability<br/>Simian virus 40--genetics<br/>Tumor Cells, Cultured<br/>Up-Regulation--genetics